Drew Davies

Nov 6, 2024 | dovepress.com | Drew Davies |Joseph W Lanario |Michael Hyland |Matthew Masoli

Introduction Asthma affects 350 million people worldwide1 with an estimated 3–10% of people diagnosed with asthma having severe asthma.2 However, these patients often describe a significant burden of living with severe asthma, accounting for a disproportionate distribution of asthma-associated morbidity and healthcare costs.3 Advances in targeted biologic therapies have expanded treatment opportunities with recognition of a subgroup of patients that describe life-changing benefits4 often...